AllianzIM U.S. Equity Buffer15 Uncapped Nov ETF (NVBU) seeks to provide exposure to U.S. equity market returns with built-in downside protection over a specific outcome period ending in November. This defined outcome ETF uses options strategies to buffer the first 15% of losses while maintaining unlimited upside participation in market gains.

How It Works

NVBU employs a sophisticated options overlay strategy that combines long positions in U.S. equity exposure with protective put spreads and call options. The fund resets annually in November, establishing new buffer and participation levels based on prevailing market conditions. This actively managed approach uses FLEX options to create the precise risk-return profile, with the options portfolio calibrated to provide exactly 15% downside protection while preserving full upside potential.

Key Features

  • Provides 15% downside buffer protection, meaning investors are shielded from the first 15% of market losses during the outcome period
  • Offers uncapped upside participation, allowing full capture of market gains above the buffer level without performance limitations
  • Annual reset in November allows for fresh buffer and participation terms based on current market volatility and interest rates

Risks

  • This ETF can lose value beyond 15% if U.S. equity markets decline more than the buffer amount, with losses accelerating dollar-for-dollar thereafter
  • Options strategies may not perform as intended if market volatility differs significantly from expectations, potentially reducing buffer effectiveness or upside participation
  • Early exit before the November outcome period ends may result in losses even within the buffer zone due to options pricing dynamics

Who Should Own This

Best suited for conservative to moderate investors with 1-year time horizons seeking equity exposure with downside protection. Appropriate as a satellite holding (10-20% allocation) for investors wanting market participation but concerned about near-term volatility. Requires medium risk tolerance and understanding that maximum benefit occurs when held through the full outcome period ending in November 2025.